The Commission has received an application for a proposed divestiture from Bayer AG concerning its recent acquisition of Aventis CropScience Holding S.A. Under the terms of the consent order conditionally approving this transaction, Bayer is required to divest certain assets. Through this application, it has petitioned the Commission to approve the divestiture of Bayer’s "Flucarbazone Assets" (as that term is defined in the order) to Arvesta Corporation. The FTC is accepting public comments on the proposed divestiture until October 18, 2002. Comments should be sent to: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Ave., NW, Washington, D.C. 20580. (FTC File No. 011-0100, Docket No. C-4049; staff contact is Wallace Easterling, Bureau of Competition, 202-326-2936; see press release dated May 30, 2002.)
Copies of the documents mentioned in this release are available from the FTC’s Web site at http://www.ftc.gov and also from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580. Call toll-free: 1-877-FTC-HELP.
Additional Contact Information